Development of a highly sensitive ctDNA assay to map the evolution of metastatic breast cancer.
Henry G. Kaplan(Swedish Medical Center), Brian Piening(Providence College), Kinsey A. McCormick, Susan Montgomery(Swedish Medical Center), Alexa K. Dowdell(Providence Portland Medical Center), Zheng Topp(Providence Portland Medical Center), David B. Page(Providence Portland Medical Center), Josiah T. Wagner(Unknown), Benjamin D. Cosgrove(Cornell University), Kelly G. Paulson(Swedish Medical Center), Danielle M. File, John Welle(Providence Health & Services), Jay Patrick Lopez(Swedish Medical Center), Bin Xie(Anhui Medical University), C. N. Carney(Swedish Medical Center), Alison Conlin(Providence Portland Medical Center), Sheila M. Reynolds(Memorial Sloan Kettering Cancer Center), Eileen Johnston, Fengting Yan(The Ohio State University Wexner Medical Center), Tanya A. Wahl(Swedish Medical Center)
Cited by 0
Related Papers
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Pathogenic Germline Variants in 10,389 Adult Cancers
|Cell|2018|904
The Immune Landscape of Cancer
|Immunity|2019|806